Pharmaceutical company Lupine Limited has received approval from the US health regulator to market the contraceptive pill generic ‘Minzoya’.
Lupine said in a stock exchange filing that the approval given by the US Food and Drug Administration (USFDA) is for Minzoya (levonorgestrel, ethinyl estradiol tablets and ferrous bisglycinate tablets) in the strengths of 0.1 mg/0.02 mg and 36.5 mg.
